Search research articles
Contact Us
Filters
Showing results (141-150 of 539) with videos related to
Page
of 54
Sort By:
British Journal of Haematology
|
July 9, 2003
Value of comparative genomic hybridization and fluorescence in situ hybridization for molecular diagnostics in multiple myeloma
Peter Liebisch, Andreas Viardot, Nicole Bassermann, et al.
Haematologica
|
November 4, 2006
The outcome of autologous stem cell transplantation in patients with plasma cell disorders and dialysis-dependent renal failure
Marc S Raab, Iris Breitkreutz, Michael Hundemer, et al.
Cancer
|
April 28, 2011
Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone
Ulrike Klein, Anna Jauch, Thomas Hielscher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2014
Dynamic contrast-enhanced magnetic resonance imaging for assessment of antiangiogenic treatment effects in multiple myeloma
Maximilian Merz, Judith Ritsch, Christina Kunz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2015
Association of antigen-specific T-cell responses with antigen expression and immunoparalysis in multiple myeloma
Sabrina Fichtner, Dirk Hose, Melanie Engelhardt, et al.
European Journal of Radiology
|
May 6, 2014
Sensitivity of whole-body CT and MRI versus projection radiography in the detection of osteolyses in patients with monoclonal plasma cell disease
Maya B Wolf, Fritz Murray, Kerstin Kilk, et al.
European Journal of Haematology
|
March 11, 2020
First-line therapy with bendamustine/prednisone/bortezomib-A GMMG trial for non-transplant eligible symptomatic multiple myeloma patients
Wolfgang Knauf, Gerrit Dingeldein, Rudolf Schlag, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
October 18, 2021
COVID-19 in multiple-myeloma patients: cellular and humoral immunity against SARS-CoV-2 in a short- and long-term view
Ivana von Metzler, Julia Campe, Sabine Huenecke, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 5, 2019
Carfilzomib-Dexamethasone Versus Bortezomib-Dexamethasone in Relapsed or Refractory Multiple Myeloma: Updated Overall Survival, Safety, and Subgroups
Robert Z Orlowski, Philippe Moreau, Ruben Niesvizky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2007
Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma
Jens Hillengass, Klaus Wasser, Stefan Delorme, et al.
Page
of 54
Search research articles
Search
Showing results (141-150 of 539) with videos related to
Sort By:
Page
of 54
British Journal of Haematology
|
July 9, 2003
Value of comparative genomic hybridization and fluorescence in situ hybridization for molecular diagnostics in multiple myeloma
Peter Liebisch, Andreas Viardot, Nicole Bassermann, et al.
Haematologica
|
November 4, 2006
The outcome of autologous stem cell transplantation in patients with plasma cell disorders and dialysis-dependent renal failure
Marc S Raab, Iris Breitkreutz, Michael Hundemer, et al.
Cancer
|
April 28, 2011
Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone
Ulrike Klein, Anna Jauch, Thomas Hielscher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2014
Dynamic contrast-enhanced magnetic resonance imaging for assessment of antiangiogenic treatment effects in multiple myeloma
Maximilian Merz, Judith Ritsch, Christina Kunz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2015
Association of antigen-specific T-cell responses with antigen expression and immunoparalysis in multiple myeloma
Sabrina Fichtner, Dirk Hose, Melanie Engelhardt, et al.
European Journal of Radiology
|
May 6, 2014
Sensitivity of whole-body CT and MRI versus projection radiography in the detection of osteolyses in patients with monoclonal plasma cell disease
Maya B Wolf, Fritz Murray, Kerstin Kilk, et al.
European Journal of Haematology
|
March 11, 2020
First-line therapy with bendamustine/prednisone/bortezomib-A GMMG trial for non-transplant eligible symptomatic multiple myeloma patients
Wolfgang Knauf, Gerrit Dingeldein, Rudolf Schlag, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
October 18, 2021
COVID-19 in multiple-myeloma patients: cellular and humoral immunity against SARS-CoV-2 in a short- and long-term view
Ivana von Metzler, Julia Campe, Sabine Huenecke, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 5, 2019
Carfilzomib-Dexamethasone Versus Bortezomib-Dexamethasone in Relapsed or Refractory Multiple Myeloma: Updated Overall Survival, Safety, and Subgroups
Robert Z Orlowski, Philippe Moreau, Ruben Niesvizky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2007
Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma
Jens Hillengass, Klaus Wasser, Stefan Delorme, et al.
Page
of 54